Regulatory Responses for OTC Products

LCH, a UK-based central counterparty clearing house, made available a resource page titled 'Regulatory Responses for OTC Products.' The page consolidates information on regulatory requirements applicable to OTC derivative clearing, including EMIR (European Market Infrastructure Regulation) compliance obligations for clearing members. The document appears to serve as a reference tool rather than establishing new compliance requirements.

Affected parties, including clearing members, buy-side firms, and market participants engaged in OTC derivative transactions, should review this resource to stay informed of regulatory expectations. While no new obligations are imposed, the consolidated guidance may assist firms in ensuring alignment with clearing mandates and reporting requirements under applicable financial market regulations.